The Effect of a Single Training Session on Changes in Inflammatory, Hormonal, and Metabolic Markers in Athletes.

NCT07264751 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2025-12-04

No results posted yet for this study

Summary

The study aims to assess the acute response of wrestlers to a single training session. Short-term changes in inflammatory, hormonal, and metabolic markers will be analyzed, which may reflect the development of fatigue and recovery processes following intense exercise. Participation in the study involves performing a standard training session and collecting blood samples at three time points to assess the physiological response. The results will provide a better understanding of the mechanisms of adaptation to exercise in strength and endurance athletes.

Conditions

  • Training
  • Inflammation Biomarkers
  • Hormone
  • Exercise Training

Interventions

BEHAVIORAL

physical training

The intervention consists of a standardized, high-intensity wrestling training session designed to simulate typical strength-endurance exercise performed by elite wrestlers. The session includes sport-specific drills, resistance exercises, and aerobic conditioning components appropriate for this athletic discipline. All participants will perform the session under supervision to ensure safety and adherence to the planned intensity and duration.

Sponsors & Collaborators

  • Poznan University of Physical Education

    lead OTHER

Principal Investigators

  • Anna Kasperska, PhD · Poznań University of Physical Education, Faculty of Sport Sciences in Gorzów Wielkopolski, Poland;

Eligibility

Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2014-05-31
Completion
2014-06-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07264751 on ClinicalTrials.gov